• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cmr3 通过标签互补来调节 III-B 型 CRISPR-Cas 系统中环寡腺苷酸合成的抑制作用。

Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

机构信息

Danish Archaea Center, Department of Biology, University of Copenhagen , Copenhagen N , Denmark.

State Key Laboratory of Agricultural Microbiology and College of Life Science and Technology, Huazhong Agricultural University , Wuhan , China.

出版信息

RNA Biol. 2019 Oct;16(10):1513-1520. doi: 10.1080/15476286.2019.1642725. Epub 2019 Jul 17.

DOI:10.1080/15476286.2019.1642725
PMID:31298604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6779384/
Abstract

Type III CRISPR-Cas systems code for a multi-subunit ribonucleoprotein (RNP) complex that mediates DNA cleavage and synthesizes cyclic oligoadenylate (cOA) second messenger to confer anti-viral immunity. Both immune activities are to be activated upon binding to target RNA transcripts by their complementarity to crRNA, and autoimmunity avoidance is determined by extended complementarity between the 5'-repeat tag of crRNA and 3'-flanking sequences of target transcripts (anti-tag). However, as to how the strategy could achieve stringent autoimmunity avoidance remained elusive. In this study, we systematically investigated how the complementarity of the crRNA 5'-tag and anti-tag (i.e., tag complementarity) could affect the interference activities (DNA cleavage activity and cOA synthesis activity) of Cmr-α, a type III-B system in Rey15A. The results revealed an increasing suppression on both activities by increasing degrees of tag complementarity and a critical function of the 7 nucleotide of crRNA in avoiding autoimmunity. More importantly, mutagenesis of Cmr3α exerts either positive or negative effects on the cOA synthesis activity depending on the degrees of tag complementarity, suggesting that the subunit, coupling with the interaction between crRNA tag and anti-tag, function in facilitating immunity and avoiding autoimmunity in Type III-B systems.

摘要

III 型 CRISPR-Cas 系统编码一个多亚基核糖核蛋白(RNP)复合物,介导 DNA 切割,并合成环状寡腺苷酸(cOA)第二信使,从而赋予抗病毒免疫。这两种免疫活性都是在通过与互补的 crRNA 结合到靶 RNA 转录本上时被激活的,而自身免疫的避免则是由 crRNA 的 5'-重复标签和靶转录本的 3'-侧翼序列(抗标签)之间的扩展互补性决定的。然而,关于这种策略如何能够实现严格的自身免疫避免,仍然难以捉摸。在这项研究中,我们系统地研究了 crRNA 5'-标签和抗标签(即标签互补性)的互补性如何影响 Cmr-α的干扰活性(DNA 切割活性和 cOA 合成活性),Cmr-α 是 Rey15A 中的 III-B 系统。结果表明,随着标签互补性的增加,两种活性都受到越来越大的抑制,并且 crRNA 的 7 个核苷酸在避免自身免疫方面具有关键功能。更重要的是,Cmr3α 的突变对 cOA 合成活性产生积极或消极的影响,这取决于标签互补性的程度,这表明该亚基与 crRNA 标签和抗标签之间的相互作用一起,在 III-B 型系统中促进免疫和避免自身免疫。

相似文献

1
Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.Cmr3 通过标签互补来调节 III-B 型 CRISPR-Cas 系统中环寡腺苷酸合成的抑制作用。
RNA Biol. 2019 Oct;16(10):1513-1520. doi: 10.1080/15476286.2019.1642725. Epub 2019 Jul 17.
2
A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.一种用于靶 RNA 捕获的种子基序可通过 III-B 型 CRISPR-Cas 系统实现有效的免疫防御。
RNA Biol. 2019 Sep;16(9):1166-1178. doi: 10.1080/15476286.2019.1618693. Epub 2019 May 26.
3
A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.III-B Cmr 效应物复合物通过协同底物结合催化环寡腺苷酸第二信使的合成。
Nucleic Acids Res. 2018 Nov 2;46(19):10319-10330. doi: 10.1093/nar/gky844.
4
Regulation of cyclic oligoadenylate synthesis by the Cas10-Csm complex.Cas10-Csm 复合物对环寡腺苷酸合成的调控。
RNA. 2019 Aug;25(8):948-962. doi: 10.1261/rna.070417.119. Epub 2019 May 10.
5
Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in .III-B CRISPR-Cas 系统靶向 RNA 切割的失活诱导. 中强烈的自身免疫反应
Int J Mol Sci. 2022 Jul 31;23(15):8515. doi: 10.3390/ijms23158515.
6
Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.III-A 型 CRISPR-Cas Csm 复合物:组装、周期性 RNA 切割、DNase 活性调节和自身免疫。
Mol Cell. 2019 Jan 17;73(2):264-277.e5. doi: 10.1016/j.molcel.2018.11.007. Epub 2018 Nov 29.
7
Control of cyclic oligoadenylate synthesis in a type III CRISPR system.III 型 CRISPR 系统中环寡腺苷酸合成的控制。
Elife. 2018 Jul 2;7:e36734. doi: 10.7554/eLife.36734.
8
Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.Cmr III-B型CRISPR-Cas效应复合物对靶RNA的捕获与切割
Genes Dev. 2014 Nov 1;28(21):2432-43. doi: 10.1101/gad.250712.114.
9
The effect of crRNA-target mismatches on cOA-mediated interference by a type III-A CRISPR-Cas system.crRNA 靶标错配对 III-A 型 CRISPR-Cas 系统介导的 cOA 干扰的影响。
RNA Biol. 2022 Jan;19(1):1293-1304. doi: 10.1080/15476286.2022.2150812.
10
Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA.Cmr1通过与靶RNA和crRNA结合,实现III-B型CRISPR-Cas系统高效的RNA和DNA干扰。
Nucleic Acids Res. 2017 Nov 2;45(19):11305-11314. doi: 10.1093/nar/gkx791.

引用本文的文献

1
Rational design of unrestricted pRN1 derivatives and their application in the construction of a dual plasmid vector system for .无限制pRN1衍生物的合理设计及其在构建用于……的双质粒载体系统中的应用。
mLife. 2024 Mar 20;3(1):119-128. doi: 10.1002/mlf2.12107. eCollection 2024 Mar.
2
Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in .III-B CRISPR-Cas 系统靶向 RNA 切割的失活诱导. 中强烈的自身免疫反应
Int J Mol Sci. 2022 Jul 31;23(15):8515. doi: 10.3390/ijms23158515.
3
Type III-A CRISPR systems as a versatile gene knockdown technology.III-A 型 CRISPR 系统作为一种通用的基因敲低技术。
RNA. 2022 Aug;28(8):1074-1088. doi: 10.1261/rna.079206.122. Epub 2022 May 26.
4
The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems.III型CRISPR-Cas系统的环状寡腺苷酸信号通路
Front Microbiol. 2021 Jan 20;11:602789. doi: 10.3389/fmicb.2020.602789. eCollection 2020.
5
CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.硫化叶菌目(Sulfolobales)中的CRISPR-Cas适应性免疫系统:遗传学研究与分子机制
Sci China Life Sci. 2021 May;64(5):678-696. doi: 10.1007/s11427-020-1745-0. Epub 2020 Oct 29.
6
Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.一种新型III型CRISPR-Cas效应器的特性研究为Cas10 DNA酶的变构激活和抑制提供了新见解。
Cell Discov. 2020 May 12;6:29. doi: 10.1038/s41421-020-0160-4. eCollection 2020.

本文引用的文献

1
Genetic Dissection of the Type III-A CRISPR-Cas System Csm Complex Reveals Roles of Individual Subunits.III-A 型 CRISPR-Cas 系统 Csm 复合物的遗传剖析揭示了各个亚基的作用。
Cell Rep. 2019 Mar 5;26(10):2753-2765.e4. doi: 10.1016/j.celrep.2019.02.029.
2
Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.III-A 型 CRISPR-Cas Csm 复合物:组装、周期性 RNA 切割、DNase 活性调节和自身免疫。
Mol Cell. 2019 Jan 17;73(2):264-277.e5. doi: 10.1016/j.molcel.2018.11.007. Epub 2018 Nov 29.
3
Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.CRISPR-Csm 复合物的结构研究揭示了共转录干扰的机制。
Cell. 2019 Jan 10;176(1-2):239-253.e16. doi: 10.1016/j.cell.2018.10.052. Epub 2018 Nov 29.
4
A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.III-B Cmr 效应物复合物通过协同底物结合催化环寡腺苷酸第二信使的合成。
Nucleic Acids Res. 2018 Nov 2;46(19):10319-10330. doi: 10.1093/nar/gky844.
5
Molecular mechanisms of CRISPR-Cas spacer acquisition.CRISPR-Cas 间隔区获取的分子机制。
Nat Rev Microbiol. 2019 Jan;17(1):7-12. doi: 10.1038/s41579-018-0071-7.
6
RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.RNA 引导互补防止 VI 型 CRISPR 系统的自我靶向。
Mol Cell. 2018 Sep 6;71(5):791-801.e3. doi: 10.1016/j.molcel.2018.07.013. Epub 2018 Aug 16.
7
PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures.CRISPR-Cas 效应物复合物对 PAM 的识别:多样化的机制和结构。
RNA Biol. 2019 Apr;16(4):504-517. doi: 10.1080/15476286.2018.1504546. Epub 2018 Sep 18.
8
Control of cyclic oligoadenylate synthesis in a type III CRISPR system.III 型 CRISPR 系统中环寡腺苷酸合成的控制。
Elife. 2018 Jul 2;7:e36734. doi: 10.7554/eLife.36734.
9
CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA.CRISPR-Cas12a对单链DNA具有顺式切割和反式切割活性。
Cell Res. 2018 Apr;28(4):491-493. doi: 10.1038/s41422-018-0022-x. Epub 2018 Mar 12.
10
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.CRISPR-Cas12a 靶向结合可释放非特异性单链 DNA 酶活性。
Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245. Epub 2018 Feb 15.